Skip to main content

Table 1 KEGG pathway analysis about the differential mRNAs in HER2-positive breast cancer

From: Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer

CategoryTermCountP value
KEGG_PATHWAYhsa04151:PI3K-Akt signaling pathway307.56E−04
KEGG_PATHWAYhsa04060:Cytokine-cytokine receptor interaction245.35E−04
KEGG_PATHWAYhsa05034:Alcoholism231.23E−05
KEGG_PATHWAYhsa05203:Viral carcinogenesis200.002068396
KEGG_PATHWAYhsa04510:Focal adhesion190.005049337
KEGG_PATHWAYhsa04110:Cell cycle183.46E−05
KEGG_PATHWAYhsa05322:Systemic lupus erythematosus189.40E 05
KEGG_PATHWAYhsa04114:Oocyte meiosis161.18E− 04
KEGG_PATHWAYhsa03320:PPAR signaling pathway146.67E−06
KEGG_PATHWAYhsa04512:ECM-receptor interaction141.20E−04
KEGG_PATHWAYhsa04152:AMPK signaling pathway140.003364429
KEGG_PATHWAYhsa04914:Progesterone-mediated oocyte maturation110.005364163
KEGG_PATHWAYhsa04974:Protein digestion and absorption110.005818118
KEGG_PATHWAYhsa04610:Complement and coagulation cascades100.003486826
KEGG_PATHWAYhsa04923:Regulation of lipolysis in adipocytes90.00327098
  1. aIf there were more than five terms enriched in this category, top 15 terms were selected according to count value. Count: the number of enriched mRNAs in each term